These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15359800)

  • 21. The treatment of hepatitis C.
    Sievert W; Batey RG
    Med J Aust; 1999 Mar; 170(5):200-2. PubMed ID: 10092915
    [No Abstract]   [Full Text] [Related]  

  • 22. Prompt arrival of antivirals against hepatitis C for HIV patients.
    Barreiro P; Vispo E
    AIDS Rev; 2010; 12(4):242-3. PubMed ID: 21344779
    [No Abstract]   [Full Text] [Related]  

  • 23. New therapeutic strategies for hepatitis C.
    Di Bisceglie AM; McHutchison J; Rice CM
    Hepatology; 2002 Jan; 35(1):224-31. PubMed ID: 11786980
    [No Abstract]   [Full Text] [Related]  

  • 24. Psychiatric comorbidity does not predict interferon treatment completion rates in hepatitis C seropositive veterans.
    Dollarhide AW; Loh C; Leckband SG; Endow-Eyer R; Robinson S; Meyer JM
    J Clin Gastroenterol; 2007 Mar; 41(3):322-8. PubMed ID: 17426475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Present status of therapy for viral hepatitis in Japan].
    Omata M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):1-4. PubMed ID: 15359754
    [No Abstract]   [Full Text] [Related]  

  • 26. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
    Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Side effects. Safety and effectiveness of interferon and ribavirin in HIV+ people co-infected with hepatitis C virus.
    TreatmentUpdate; 2001; 12(8):4-5. PubMed ID: 12132439
    [No Abstract]   [Full Text] [Related]  

  • 28. Current issues in hepatitis C, HIV co-infection discussed at lunch and learn.
    Monarch A
    Surviv News (Atlanta Ga); 2002 Sep; ():14. PubMed ID: 12765135
    [No Abstract]   [Full Text] [Related]  

  • 29. Focus on hepatitis. Increased RBV dose for better HCV treatment response.
    Bernard EJ
    IAPAC Mon; 2006 Jan; 12(1):18. PubMed ID: 17249131
    [No Abstract]   [Full Text] [Related]  

  • 30. Mechanism of action of interferon and ribavirin in treatment of hepatitis C.
    Feld JJ; Hoofnagle JH
    Nature; 2005 Aug; 436(7053):967-72. PubMed ID: 16107837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of interferon plus ribavirin combination in the treatment of naive patients with hepatitis C virus type 5. A French multicentre retrospective study.
    Bonny C; Fontaine H; Poynard T; Hézode C; Larrey D; Marcellin P; Bourlière M; Bronowicki JP; Merle P; Zarski JP; Sapey T; Guillemard C; Ughetto S; Henquell C; Nicolas C; Roche C; Randl K; Bommelaer G; Abergel A
    Aliment Pharmacol Ther; 2006 Aug; 24(4):593-600. PubMed ID: 16907892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical management of asymptomatic HCV carriers].
    Nakamura I; Ochiai K; Imawari M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):396-9. PubMed ID: 15359829
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: low eligibility for interferon treatment.
    Fleming CA; Craven DE; Thornton D; Tumilty S; Nunes D
    Clin Infect Dis; 2003 Jan; 36(1):97-100. PubMed ID: 12491208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical guidelines of diagnosis and treatment of hepatitis C].
    Rev Gastroenterol Mex; 2007; 72(2):177-91. PubMed ID: 17966381
    [No Abstract]   [Full Text] [Related]  

  • 35. Recurrence of hepatitis C after liver transplantation.
    Friman S
    Transplant Proc; 2005 Oct; 37(8):3311-2. PubMed ID: 16298582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C in schizophrenia: screening experience in a community-dwelling clozapine cohort.
    Freudenreich O; Gandhi RT; Walsh JP; Henderson DC; Goff DC
    Psychosomatics; 2007; 48(5):405-11. PubMed ID: 17878499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies for hepatitis C therapeutic intervention: now and next.
    Tan SL; He Y; Huang Y; Gale M
    Curr Opin Pharmacol; 2004 Oct; 4(5):465-70. PubMed ID: 15351350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shall we treat all patients with hepatitis C, and if not, why? Certainly, injecting drug users must not be an exclusion criterion.
    Tillmann HL; Thompson AJ
    Digestion; 2008; 78(2-3):120-2. PubMed ID: 19023206
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of hepatitis C in Rhode Island: opportunities for improvement within and beyond the department of corrections.
    Berzin T; Allen S; Taylor L; Rich J; Feller E
    Med Health R I; 2002 Nov; 85(11):341-4. PubMed ID: 12462866
    [No Abstract]   [Full Text] [Related]  

  • 40. Assessment of specific antibodies to F protein in serum samples from Chinese hepatitis C patients treated with interferon plus ribavarin.
    Gao DY; Zhang XX; Hou G; Jin GD; Deng Q; Kong XF; Zhang DH; Ling Y; Yu DM; Gong QM; Zhan Q; Yao BL; Lu ZM
    J Clin Microbiol; 2008 Nov; 46(11):3746-51. PubMed ID: 18832124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.